Home › NDC Lookup › RxCUI directory › RxCUI 854896

Zolpidem tartrate 6.25 MG Extended Release Oral Tablet [Ambien] — RxCUI 854896

RxNorm drug concept · Semantic branded drug
RxCUI 854896 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI854896
Official nameZolpidem tartrate 6.25 MG Extended Release Oral Tablet [Ambien]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAmbien CR 6.25 MG Extended Release Oral Tablet
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)332 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Zolpidem: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Zolpidem treats insomnia. Depending on the product, it helps you fall asleep, stay asleep, or get back to sleep after waking in the middle of the night. Most are meant for short-te...
  • Take it right at bedtime, only when you can get a full 7 to 8 hours of sleep. Try not to take it with or right after a meal, since food can slow it down. Swallow extended-release t...
  • No, please avoid it. Alcohol adds to drowsiness and can make your coordination and alertness worse. The same goes for other sedating medicines, so tell me everything you take.
  • Zolpidem can cause next-day impairment even when you feel fine. Avoid driving or anything that needs full alertness if you took more than directed, had less than a full night to sl...
📖 Read our full Zolpidem guide →

🕸️ Concept Web — How Zolpidem tartrate 6.25 MG Extended Release Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zolpidem tartrate 6.25 MG Extended Release Oral Tablet [Ambien] RxCUI 854896

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Zolpidem 39993
    • Zolpidem tartrate 221183
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ambien 131725
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zolpidem Extended Release Oral Tablet 577086
    • Zolpidem tartrate Extended Release Oral Tablet 2646303
    • Zolpidem Oral Product 1156259
    • Zolpidem Pill 1156260
    • Zolpidem tartrate Oral Product 2660744
    • Zolpidem tartrate Pill 2661550
    • Zolpidem Extended Release Oral Tablet [Ambien] 602454
    • Zolpidem tartrate Extended Release Oral Tablet [Ambien] 2655366
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zolpidem tartrate 6.25 MG Extended Release Oral Tablet SCD · 854894
  • Zolpidem tartrate 6.25 MG SCDC · 854893
  • Zolpidem Extended Release Oral Tablet SCDF · 577086
  • Zolpidem tartrate Extended Release Oral Tablet SCDFP · 2646303
  • Zolpidem Oral Product SCDG · 1156259
  • Zolpidem Pill SCDG · 1156260
  • Zolpidem tartrate Oral Product SCDGP · 2660744
  • Zolpidem tartrate Pill SCDGP · 2661550

Brand-Name Concepts

  • Zolpidem tartrate 6.25 MG [Ambien] SBDC · 854895
  • Zolpidem Extended Release Oral Tablet [Ambien] SBDF · 602454
  • Zolpidem tartrate Extended Release Oral Tablet [Ambien] SBDFP · 2655366
  • Ambien Oral Product SBDG · 1170672
  • Ambien Pill SBDG · 1170673
  • Ambien BN · 131725

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 854896 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00024-5521-31 100 TABLET, COATED in 1 BOTTLE (0024-5521-31) Ambien CR Sanofi-Aventis U.S. LLC 2005-09-19
00713-5501-01 100 TABLET, COATED in 1 BOTTLE (0713-5501-01) Ambien CR Cosette Pharmaceuticals, Inc. 2025-02-07
00713-5521-01 100 TABLET, COATED in 1 BOTTLE (0713-5521-01) Ambien CR Cosette Pharmaceuticals, Inc. 2025-02-07
Observed labelers: Cosette Pharmaceuticals, Inc. (2) · Sanofi-Aventis U.S. LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.